• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

What's Hot in Biologics for Psoriasis?

Video
Conference|American Academy of Dermatology

Mark Lebwohl, MD, discusses his recent presentation from AAD VMX 2021 regarding new data for various biologics for the treatment of psoriasis.

Related Videos
Related Content
Half of Patients With Psoriasis Receiving Placebo In Clinical Trials Report Adverse Events

Half of Patients With Psoriasis Receiving Placebo In Clinical Trials Report Adverse Events

Article
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Podcast
Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis

Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis

Article
The Cutaneous Connection: An Inside Look of the Inclusive Atlas

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

Podcast
Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks

Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks

Article
Topical Melatonin and Rosuvastatin Reduce Severity of Mild to Moderate Plaque Psoriasis

Topical Melatonin and Rosuvastatin Reduce Severity of Mild to Moderate Plaque Psoriasis

Article
© 2024 MJH Life Sciences

All rights reserved.